These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23147542)

  • 1. Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.
    Then C; Hörauf N; Otto S; Pautke C; von Tresckow E; Röhnisch T; Baumann P; Schmidmaier R; Bumeder I; Oduncu FS
    Onkologie; 2012; 35(11):658-64. PubMed ID: 23147542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of bisphosphonate-related osteonecrosis of the jaw after kidney transplantation.
    Park W; Lee SH; Park KR; Rho SH; Chung WY; Kim HJ
    J Craniofac Surg; 2012 Sep; 23(5):e510-4. PubMed ID: 22976726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
    Thumbigere-Math V; Tu L; Huckabay S; Dudek AZ; Lunos S; Basi DL; Hughes PJ; Leach JW; Swenson KK; Gopalakrishnan R
    Am J Clin Oncol; 2012 Aug; 35(4):386-92. PubMed ID: 22561331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma.
    Jarnbring F; Kashani A; Björk A; Hoffman T; Krawiec K; Ljungman P; Lund B
    Br J Oral Maxillofac Surg; 2015 Dec; 53(10):1007-11. PubMed ID: 26530732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
    Taylor T; Bryant C; Popat S
    Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A; Almas K; Javed F
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
    Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients.
    Watters AL; Hansen HJ; Williams T; Chou JF; Riedel E; Halpern J; Tunick S; Bohle G; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):192-200. PubMed ID: 23036797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws.
    Wutzl A; Pohl S; Sulzbacher I; Seemann R; Lauer G; Ewers R; Drach J; Klug C
    Head Neck; 2012 Feb; 34(2):194-200. PubMed ID: 21400630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation.
    Blimark C; Veskovski L; Westin J; Rödjer S; Brune M; Hjorth M; Holmberg E; Andersson PO; Mellqvist UH
    Eur J Haematol; 2011 Aug; 87(2):117-22. PubMed ID: 21535157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic cancer identified in osteonecrosis specimens of the jaws in patients receiving intravenous bisphosphonate medications.
    Carlson ER; Fleisher KE; Ruggiero SL
    J Oral Maxillofac Surg; 2013 Dec; 71(12):2077-86. PubMed ID: 23945512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P; Nammour S
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical investigation of bisphosphonate-related osteonecrosis of the jaws].
    Dehari H; Tomihara K; Ueda M; Shimanishi M; Ono M; Sasaki T; Igarashi T; Shiratori K; Abe M; Ogi K; Nakamori K; Miyazaki A; Nagai I; Hiratsuka H
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2587-92. PubMed ID: 20009460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.
    Vescovi P; Manfredi M; Merigo E; Guidotti R; Meleti M; Pedrazzi G; Fornaini C; Bonanini M; Ferri T; Nammour S
    Photomed Laser Surg; 2012 Jan; 30(1):5-13. PubMed ID: 22054203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
    Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS
    Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.